Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,379 | 525 | 99.2% |
| Education | $71.01 | 6 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,605 | 106 | $0 (2023) |
| Lilly USA, LLC | $1,126 | 68 | $0 (2023) |
| ABBVIE INC. | $698.03 | 22 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $680.48 | 40 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $569.10 | 33 | $0 (2019) |
| Amarin Pharma Inc. | $500.98 | 15 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $461.13 | 25 | $0 (2020) |
| Allergan, Inc. | $449.03 | 26 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $397.86 | 18 | $0 (2024) |
| GlaxoSmithKline, LLC. | $391.56 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $145.88 | 8 | Exact Sciences Corporation ($56.43) |
| 2023 | $204.94 | 10 | Corcept Therapeutics ($68.46) |
| 2022 | $38.16 | 2 | Takeda Pharmaceuticals U.S.A., Inc. ($26.33) |
| 2021 | $478.68 | 27 | Takeda Pharmaceuticals U.S.A., Inc. ($87.66) |
| 2020 | $889.56 | 36 | GlaxoSmithKline, LLC. ($159.73) |
| 2019 | $2,392 | 153 | Novo Nordisk Inc ($721.27) |
| 2018 | $2,218 | 138 | Novo Nordisk Inc ($541.16) |
| 2017 | $3,084 | 157 | Lilly USA, LLC ($464.50) |
All Payment Transactions
531 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Oncology | ||||||
| 07/22/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Oncology | ||||||
| 04/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: RESPIRATORY | ||||||
| 03/18/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: Oncology | ||||||
| 02/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: NEUROSCIENCE | ||||||
| 02/20/2024 | GlaxoSmithKline, LLC. | BEXSERO (Biological), SHINGRIX, MENVEO | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: VACCINES | ||||||
| 11/30/2023 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: Endocrinology | ||||||
| 11/06/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Diabetes | ||||||
| 10/26/2023 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: Endocrinology | ||||||
| 09/22/2023 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: Endocrinology | ||||||
| 08/22/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: DIABETES | ||||||
| 08/14/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: PAIN | ||||||
| 07/31/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Respiratory | ||||||
| 07/18/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Diabetes | ||||||
| 06/26/2023 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $30.03 | General |
| Category: Endocrinology | ||||||
| 05/09/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Obesity | ||||||
| 03/15/2022 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: Diabetes | ||||||
| 01/13/2022 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $26.33 | General |
| Category: NEUROSCIENCE | ||||||
| 12/07/2021 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $26.88 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2021 | Adlon Therapeutics L.P. | ADHANSIA XR (Drug) | Food and Beverage | Cash or cash equivalent | $14.67 | General |
| Category: PRESCRIPTION STIMULANT | ||||||
| 10/06/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Diabetes | ||||||
| 09/29/2021 | Lilly USA, LLC | EMGALITY (Drug), TRULICITY | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Neuroscience | ||||||
| 09/21/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 34 | 38 | $836.00 | $300.38 |
| 2022 | 9 | 594 | 706 | $87,791 | $38,875 |
| 2021 | 10 | 384 | 535 | $82,752 | $42,204 |
| 2020 | 12 | 985 | 1,187 | $303,786 | $80,012 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 83036 | Hemoglobin a1c level | Office | 2023 | 17 | 20 | $440.00 | $190.40 | 43.3% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 17 | 18 | $396.00 | $109.98 | 27.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 196 | 246 | $47,478 | $20,285 | 42.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 77 | 77 | $17,633 | $9,480 | 53.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 52 | 59 | $7,670 | $3,208 | 41.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 14 | $3,654 | $1,949 | 53.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 20 | 20 | $1,900 | $1,364 | 71.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $4,284 | $1,326 | 31.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 158 | 204 | $3,876 | $602.94 | 15.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 20 | 20 | $880.00 | $544.50 | 61.9% |
| 81003 | Automated urinalysis test | Office | 2022 | 46 | 52 | $416.00 | $115.41 | 27.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 96 | 207 | $38,916 | $20,132 | 51.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 50 | 50 | $11,450 | $6,282 | 54.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 49 | 73 | $9,344 | $4,941 | 52.9% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2021 | 18 | 18 | $6,498 | $4,289 | 66.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 36 | 36 | $11,016 | $4,181 | 38.0% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 21 | 21 | $1,995 | $1,366 | 68.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 27 | 27 | $1,188 | $424.98 | 35.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 23 | 23 | $1,012 | $362.02 | 35.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 50 | 63 | $1,197 | $189.00 | 15.8% |
| 81003 | Automated urinalysis test | Office | 2021 | 14 | 17 | $136.00 | $38.25 | 28.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 286 | 427 | $138,348 | $30,428 | 22.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 243 | 243 | $103,518 | $28,233 | 27.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 78 | 89 | $19,580 | $4,532 | 23.1% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 78 | 84 | $4,116 | $4,092 | 99.4% |
About Dr. Michael Timmel, MD
Dr. Michael Timmel, MD is a Family Medicine healthcare provider based in Cleveland, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1760472096.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Timmel, MD has received a total of $9,450 in payments from pharmaceutical and medical device companies, with $145.88 received in 2024. These payments were reported across 531 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($9,379).
As a Medicare-enrolled provider, Timmel has provided services to 1,997 Medicare beneficiaries, totaling 2,466 services with total Medicare billing of $161,392. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Cleveland, GA
- Active Since 10/27/2005
- Last Updated 04/13/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1760472096
Products in Payments
- TRULICITY (Drug) $740.39
- Ozempic (Drug) $694.67
- INVOKANA (Drug) $529.82
- Vascepa (Drug) $500.98
- FARXIGA (Drug) $424.37
- JARDIANCE (Drug) $419.13
- Victoza (Drug) $352.13
- Synthroid (Drug) $256.21
- Aimovig (Biological) $229.22
- VRAYLAR (Drug) $202.53
- XIFAXAN (Drug) $195.42
- SOLIQUA (Drug) $187.98
- LINZESS (Drug) $179.30
- Saxenda (Drug) $179.04
- TOUJEO (Drug) $175.47
- TRELEGY ELLIPTA (Drug) $173.35
- DUEXIS (Drug) $168.85
- Androgel (Drug) $148.02
- EMGALITY (Drug) $146.32
- SHINGRIX (Drug) $137.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Cleveland
Dominic King, D.o, D.O
Family Medicine — Payments: $337,674
Jeannette Potts, Md, MD
Family Medicine — Payments: $30,044
Meaghan Combs, Md, MD
Family Medicine — Payments: $25,727
George Stokes, Md, MD
Family Medicine — Payments: $18,678
Dr. Charles Brock, M.d, M.D
Family Medicine — Payments: $9,519
Mr. Cecil Breetzke, Md, MD
Family Medicine — Payments: $9,499